ERYTECH provides financial update for Q3 2013 Post author:admERY Post published:November 5, 2013 Post category:Newsroom ERYTECH announces today its cash position and its revenues for the third quarter of 2013. You Might Also Like ERYTECH Announces Completion of First Cohort in a Phase 1 Investigator Sponsored Trial of Eryaspase in First-Line Pancreatic Cancer April 19, 2021 ERYTECH PHARMA launches a subscription of BSPCE warrants reserved for its main executives January 28, 2014 ERYTECH to Host on September 22, 2020 Second Quarter 2020 Conference Call and Business Update September 16, 2020
ERYTECH Announces Completion of First Cohort in a Phase 1 Investigator Sponsored Trial of Eryaspase in First-Line Pancreatic Cancer April 19, 2021
ERYTECH PHARMA launches a subscription of BSPCE warrants reserved for its main executives January 28, 2014
ERYTECH to Host on September 22, 2020 Second Quarter 2020 Conference Call and Business Update September 16, 2020
